Fajardo, Rudy A.
HRN: 08-37-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/18/2024
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
08/18/2024
08/25/2024
IV
4.5 G
Every 8 Hours
S/P Ex Lap
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes